Product code QUR— Ophthalmic

Essilor® Stellest®

Classification name
Prescription Spectacle Lenses To Reduce The Progression Of Myopia
Device class
Class 2
Regulation
21 CFR 886.5845
Advisory panel
Ophthalmic
Total cleared
1
First cleared
Most recent

FDA classification definition

“Prescription spectacle lenses to reduce the progression of myopia consist of spectacle lenses with additional physical optical design lens elements. In addition to optical correction of myopic refractive error, these lenses are intended to be used by children who have myopia to reduce the rate of myopia progression. The lenses are mounted within a spectacle frame classified under § 886.5842.”

— U.S. Food and Drug Administration, device classification record for product code QUR under 21 CFR 886.5845, via openFDA

Market context for product code QUR

FDA has cleared 1 device under product code QUR, all in 2025, filed by 1 applicant company. No FDA device recalls reference this product code. Class II devices are moderate-risk and subject to general and special controls; most reach market through 510(k) clearance by demonstrating substantial equivalence to a predicate device.

Top applicants under product code QUR

Recent clearances under product code QUR

Data sourced from openFDA. This site is unofficial and independent of the FDA.